Harvard Bioscience, Inc. (HBIO)
NASDAQ · Healthcare
Harvard Bioscience, Inc. Revenue 2009–2025
Harvard Bioscience, Inc. annual/quarterly revenue history and growth rate from 2009 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Harvard Bioscience, Inc. revenue for the quarter ending March 31, 2026 was 20.8 M, a 4.68% decrease year-over-year.
- Harvard Bioscience, Inc. revenue for the twelve months ending March 31, 2026 was 83.6 M, a 11.98% decrease year-over-year.
- Harvard Bioscience, Inc. annual revenue for 2025 was 86.5 M, a 8.06% decrease from 2024.
- Harvard Bioscience, Inc. annual revenue for 2024 was 94.1 M, a 16.14% decrease from 2023.
- Harvard Bioscience, Inc. annual revenue for 2023 was 112.3 M, a 0.96% decrease from 2022.
- Harvard Bioscience, Inc. annual revenue for 2022 was 113.3 M.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Harvard Bioscience, Inc. Revenue — FAQ
Harvard Bioscience, Inc. (HBIO) revenue over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
What is Harvard Bioscience, Inc.'s revenue?
Harvard Bioscience, Inc. (HBIO) reported revenue of $87M for fiscal 2025.
Where can I see HBIO's revenue history?
The chart and table above show Harvard Bioscience, Inc.'s revenue by year and by quarter, including the growth rate.